Coya Therapeutics, Inc. (COYA)
5.01
+0.12
(+2.45%)
USD |
NASDAQ |
Sep 21, 16:00
5.01
0.00 (0.00%)
After-Hours: 20:00
Coya Therapeutics Market Cap : 117.52M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 114.71M |
| September 17, 2026 | 111.66M |
| September 16, 2026 | 104.62M |
| September 15, 2026 | 109.08M |
| September 14, 2026 | 108.84M |
| September 11, 2026 | 102.75M |
| September 10, 2026 | 106.03M |
| September 09, 2026 | 108.14M |
| September 08, 2026 | 108.14M |
| September 04, 2026 | 111.66M |
| September 03, 2026 | 106.73M |
| September 02, 2026 | 103.68M |
| September 01, 2026 | 105.79M |
| August 31, 2026 | 106.97M |
| August 28, 2026 | 107.67M |
| August 27, 2026 | 114.00M |
| August 26, 2026 | 114.24M |
| August 25, 2026 | 118.23M |
| August 24, 2026 | 116.35M |
| August 21, 2026 | 114.24M |
| August 20, 2026 | 114.00M |
| August 19, 2026 | 116.59M |
| August 18, 2026 | 115.41M |
| August 17, 2026 | 109.55M |
| August 14, 2026 | 112.36M |
| Date | Value |
|---|---|
| August 13, 2026 | 109.55M |
| August 12, 2026 | 110.02M |
| August 11, 2026 | 112.60M |
| August 10, 2026 | 108.84M |
| August 07, 2026 | 112.83M |
| August 06, 2026 | 107.44M |
| August 05, 2026 | 106.73M |
| August 04, 2026 | 107.20M |
| August 03, 2026 | 103.92M |
| July 31, 2026 | 98.29M |
| July 30, 2026 | 95.71M |
| July 29, 2026 | 90.78M |
| July 28, 2026 | 93.83M |
| July 27, 2026 | 100.04M |
| July 24, 2026 | 99.69M |
| July 23, 2026 | 102.74M |
| July 22, 2026 | 102.51M |
| July 21, 2026 | 106.73M |
| July 20, 2026 | 104.15M |
| July 17, 2026 | 106.50M |
| July 16, 2026 | 107.90M |
| July 15, 2026 | 113.53M |
| July 14, 2026 | 114.24M |
| July 13, 2026 | 113.88M |
| July 10, 2026 | 123.38M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.710B |
| Oncolytics Biotech, Inc. | 95.71M |
| Sangamo Therapeutics, Inc. | 60.03M |
| Sarepta Therapeutics, Inc. | 2.126B |
| Anixa Biosciences, Inc. | 93.38M |
Market Cap Related Metrics
| PS Ratio | 13.08 |
| Price to Book Value | 2.716 |
| Price | 5.01 |
| Earnings Yield | -19.97% |